Calvin Yu

Inga fler pågående positioner

50 år

Health Technology

Consumer Services

Profil

Calvin Yu worked as Senior Director-Finance & SEC Reporting at Adverum Biotechnologies, Inc. from 2014 to 2016.
Prior to that, he worked as Controller at Five Prime Therapeutics, Inc. from 2010 to 2014.
He also worked as Controller at Stemcentrx, Inc. from 2016 to 2017.
Currently, he is the Chief Financial & Accounting Officer at Alector, Inc. Mr. Yu completed his undergraduate degree from San Francisco State University.

Tidigare kända positioner av Calvin Yu

Företag	Position	Slut
Stemcentrx, Inc. Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients	Comptroller/Controller/Revisor	2017-06-01
ADVERUM BIOTECHNOLOGIES, INC.	Finansdirektör/CFO	2016-02-01
FIVE PRIME THERAPEUTICS, INC.	Comptroller/Controller/Revisor	2014-09-01
ALECTOR, INC.	Finansdirektör/CFO	2021-09-08

Se detaljerna i Calvin Yus erfarenhet

Calvin Yus utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Calvin Yus erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases	Health Technology
Stemcentrx, Inc. Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients	Health Technology
San Francisco State University San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Adverum Biotechnologies, Inc. Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies	Health Technology
Alector, Inc. Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders	Health Technology